TAFA5
TAFA5 (TAFA chemokine like family member 5, also known as TAFA-5 or FAM19A5) is a small secreted chemokine-like protein of the TAFA family. It regulates cell proliferation and migration by activating G protein-coupled receptors, including S1PR2 and FPR2. Browse Assay Genie's current range of TAFA5 research reagents below, or read on for the biology behind the target.
TAFA5 acts as a chemokine-like protein, regulating cell proliferation and migration through activation of G protein-coupled receptors (GPCRs) such as S1PR2 and FPR2. In macrophages it stimulates chemotactic migration via the MAPK3/ERK1 and AKT1 pathway. It also blocks TNFSF11/RANKL-induced osteoclast formation from macrophages by inhibiting up-regulation of osteoclast fusogenic and differentiation genes. Both the migration and the anti-osteoclast effects are mediated through FPR2.
TAFA5 also acts as an adipokine. It negatively regulates the proliferation and migration of vascular smooth muscle cells (VSMCs) in response to platelet-derived growth factor, signalling through S1PR2 and the G protein GNA12/GNA13-transmitted RHOA pathway. It inhibits injury-induced cell proliferation and neointima formation in the femoral arteries. Researchers studying the TAFA5 protein therefore work across immune, bone and vascular biology.
The TAFA5 gene belongs to the TAFA family, which comprises five highly homologous genes encoding small secreted proteins. These proteins contain conserved cysteine residues at fixed positions and are distantly related to MIP-1alpha, a member of the CC-chemokine family. TAFA proteins are predominantly expressed in specific regions of the brain and are postulated to act as brain-specific chemokines or neurokines that regulate immune and nervous cells. The gene was previously named family with sequence similarity 19 member A5 (FAM19A5) and C-C motif chemokine like, reflecting this relationship to the chemokines. Mouse and rat each have a Tafa5 ortholog.
TAFA proteins are enriched in specific brain regions and are postulated to act as neurokines that regulate immune and nervous cells.
TAFA5 stimulates macrophage chemotaxis through FPR2 and the MAPK3/ERK1 and AKT1 pathway.
TAFA5 blocks RANKL-induced osteoclast formation from macrophages by suppressing fusogenic and differentiation genes.
TAFA5 limits PDGF-driven smooth muscle proliferation and migration via S1PR2 and RHOA, and inhibits neointima formation after arterial injury.
TAFA5 is a secreted chemokine-like protein that activates GPCRs including S1PR2 and FPR2. It drives macrophage migration, blocks RANKL-induced osteoclast formation and, as an adipokine, restrains vascular smooth muscle cell proliferation and migration in response to PDGF.
TAFA5 is also written TAFA-5 or FAM19A5. UniProt lists the protein as chemokine-like protein TAFA-5. Earlier gene names were family with sequence similarity 19 member A5 and C-C motif chemokine like. HGNC places it in the TAFA chemokine like family.
TAFA5 is one of five highly homologous TAFA family members with conserved cysteines, distantly related to the CC-chemokine MIP-1alpha. Mouse and rat both have a Tafa5 ortholog; check the datasheet of any product for its validated reactivity.
Receptors, signalling partners and pathway components linked to TAFA5 function, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q7Z5A7; product specifications from Assay Genie datasheets.